Ticlopidine Hydrochloride Tablets

Antiplatelet aggregation drugs can inhibit platelet aggregation caused by various inducers such as ADP, collagen, thrombin, arachidonic acid and prostaglandin endoperoxides, and can inhibit platelet aggregation reactions induced by exogenous and endogenous ADP.

The main ingredient of this product is: Ticlopidine hydrochloride.

Sugar-coated tablets are white or off-white after removing the sugar coating.

Prevent and treat circulatory disorders of the heart, brain and other arteries caused by high platelet aggregation.

Oral: 1 tablet (0.25g) once a day, taken with meals to reduce mild gastrointestinal reactions.

1. Occasionally mild gastrointestinal reactions. 2. Rare reactions: nausea, diarrhea, rash, ecchymosis, gingival bleeding, leukopenia, cholestasis, mild elevation of aminotransferase, mucocutaneous bleeding tendency. 3. All the above adverse reactions disappear after discontinuation of the drug.

1. Patients with recent bleeding; 2. Patients with recent ulcer disease with bleeding tendency or prolonged bleeding time; 3. Patients with allergies; 4. Patients with a history of leukopenia, thrombocytopenia, granulocytopenia or patients with aplastic anemia.

Not yet clear.

Keep away from light and sealed. Valid for 2 years.

0.25g

Jinyao Darrentang Group Co., Ltd. Xinxin Pharmaceutical Factory

• Founded in:

  2000-10-20

• Address:

  Chenglinzhuang Industrial Zone, Tianjin

• Tax NO.:

  91120110103738323L

• Registered Funds:

  -

• Email:

  Log in to view